Trial intelligence / Profile preview

Perioperative physostigmine prophylaxis for liver resection patients at risk for delirium and postoperative cognitive dysfunction

2008-007237-47Phase 4Terminated

Sponsor
Charité – Universitätsmedizin Berlin
Start
Nov 2008
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of physostigmine in delirium, post-operative cognitive decline (POCD), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2008; status: terminated.

02

Drugs

physostigmine
03

Conditions

deliriumpost-operative cognitive decline (POCD)

Beyond the preview

Go deeper on 2008-007237-47.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007237-47.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call